Jason Haddock
Direktor/Vorstandsmitglied bei PYC THERAPEUTICS LIMITED
Vermögen: - $ am 30.04.2024
Profil
Jason Haddock is currently a Non-Executive Director at PYC Therapeutics Ltd.
and Merus NV.
Previously, he served as an Independent Director at Codiak BioSciences, Inc. from 2020 to 2023.
He also held the position of Chief Financial & Operating Officer at Bristol Myers Squibb Co. from 2001 to 2015 and CFO & Principal Accounting Officer at Array BioPharma, Inc. from 2016 to 2019.
Additionally, he was the Chief Operating & Finance Officer at Berg LLC from 2015 to 2016.
Mr. Haddock's education includes an undergraduate degree from Illinois State University and an MBA from Olin Business School.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
PYC THERAPEUTICS LIMITED
-.--% | 30.06.2023 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Jason Haddock
Unternehmen | Position | Beginn |
---|---|---|
PYC THERAPEUTICS LIMITED | Direktor/Vorstandsmitglied | 29.03.2021 |
MERUS N.V. | Direktor/Vorstandsmitglied | 07.05.2024 |
Ehemalige bekannte Positionen von Jason Haddock
Unternehmen | Position | Ende |
---|---|---|
CODIAK BIOSCIENCES | Direktor/Vorstandsmitglied | 01.06.2023 |
ARRAY TECHNOLOGIES, INC. | Finanzdirektor/CFO | 01.07.2019 |
Berg LLC
Berg LLC Pharmaceuticals: MajorHealth Technology Berg LLC operates as a biopharmaceutical company, which focuses on taking a bold back to biology approach to therapeutic discovery using its Interrogative Biology platform. Its therapeutics include cancer metabolism and BPM 31510, chemotherapy induced alopecia and BPM 315453, neurology-discovery program, and metabolic disease-discovery program. The company was founded by Carl Edwin Berg, Mitch Gray, and Niven R. Narain in 2006 and is headquartered in Framingham, MA. | Finanzdirektor/CFO | 01.07.2016 |
BRISTOL-MYERS SQUIBB COMPANY | Finanzdirektor/CFO | 01.01.2015 |
ArcherDX LLC
ArcherDX LLC Packaged SoftwareTechnology Services ArcherDX LLC is a genomic analysis company, which develops software solutions for investigating cancer treatment. Its products include VariantPlex, FusionPlex, LiquidPlex, reveal ctDNA, Immunoverse, custom assays, and archer analysis. The company was founded by Jason W. Myers, A. John Iafrate, and Long Phi Le on January 1, 2013 and is headquartered in Boulder, CO. | Finanzdirektor/CFO | - |
Ausbildung von Jason Haddock
Illinois State University | Undergraduate Degree |
Olin Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
PYC THERAPEUTICS LIMITED | Health Technology |
MERUS N.V. | Health Technology |
Private Unternehmen | 4 |
---|---|
Array BioPharma, Inc.
Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
Berg LLC
Berg LLC Pharmaceuticals: MajorHealth Technology Berg LLC operates as a biopharmaceutical company, which focuses on taking a bold back to biology approach to therapeutic discovery using its Interrogative Biology platform. Its therapeutics include cancer metabolism and BPM 31510, chemotherapy induced alopecia and BPM 315453, neurology-discovery program, and metabolic disease-discovery program. The company was founded by Carl Edwin Berg, Mitch Gray, and Niven R. Narain in 2006 and is headquartered in Framingham, MA. | Health Technology |
ArcherDX LLC
ArcherDX LLC Packaged SoftwareTechnology Services ArcherDX LLC is a genomic analysis company, which develops software solutions for investigating cancer treatment. Its products include VariantPlex, FusionPlex, LiquidPlex, reveal ctDNA, Immunoverse, custom assays, and archer analysis. The company was founded by Jason W. Myers, A. John Iafrate, and Long Phi Le on January 1, 2013 and is headquartered in Boulder, CO. | Technology Services |
Codiak BioSciences, Inc.
Codiak BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Codiak BioSciences, Inc. engages in the development and manufacturing of exosomes. It engages in harnessing exosomes, therapeutic applications, diagnostic applications, and proprietary production. The firm develops engEx Platform, a proprietary and versatile exosome engineering and manufacturing platform, to expand upon the innate properties of exosomes to design novel exosome therapeutics. Codiak BioSciences was founded by Douglas E. William, Raghu Kalluri, and Eric S. Lander in 2015 and is headquartered in Cambridge, MA. | Health Technology |